Skip to content

Undeclared drug found in a slimming product

Undeclared drug found in a slimming product
18 November 2008

The Department of Health today (November 18) appealed to members of the public not to buy or use a slimming product named "Relacore" as it was found to have contained an undeclared drug that may cause serious side effect.

The appeal was made following DH's investigations into a report concerning a 23-year-old woman who developed symptoms of palpitation, hand tremors and shortness of breath on October 28. She attended Accident and Emergency Department of Yan Chai Hospital on November 3 and no hospitalization was required.

Investigation revealed that she had taken the above product, which was obtained from her friends, before the onset of symptoms.

A spokesman for the department said that laboratory tests on the product sample today showed the presence of sibutramine.

Sibutramine is a western medicine used as appetite suppressant for slimming under close medical supervision. Its side effects include increased blood pressure and heart rate, symptoms of psychosis, and possibly convulsion. People with heart problems should not take it.

Under the Pharmacy and Poisons Ordinance, it must be registered with the Pharmacy and Poisons Board and can only be sold on a doctor's prescription and under supervision of a pharmacist.

Possession or sale of unregistered pharmaceutical product is liable on conviction to a $100,000 fine and two years' imprisonment.

He appealed to members of the public who have been using the above product to stop using it immediately. They should consult their medical professionals for advice if they feel unwell.

They should destroy and dispose of the products or submit them to the department's Pharmaceutical Service at 3/F, Public Health Laboratory Centre, 382 Nam Cheong Street , Kowloon during office hours.

The spokesman stressed that a balanced diet and exercise are crucial factors in keeping fit and healthy. Members of the public who want to reduce weight are advised to consult medical professionals first.

Ends/Tuesday, November 18, 2008